is glp 1 or glp 2 better for weight loss What Happens After GLP-1 Loss? Is Mounjaro the Same as

rare serious risks include pancreatitis and gallbladder disease

Expected Approval Timeline Based on Phase 3 trial completion estimates and typical regulatory review timelines, FDA approval is projected for late 2026 to early 2027

Doses are increased gradually over time which allows your body to get used to the medication and serves to lessen side effects

Patch wear time: How many hours per day should the patch stay on before removal

Months 6 to 12 and beyond: maximum results and maintenance The STEP trials showed that semaglutide 2.4 mg produces an average of approximately 15% body weight loss by week 68, roughly 16 months

The weight loss and metabolic improvements dramatically reduce cardiovascular risk, far outweighing any heart rate concern